News | May 12, 2023
Bliss GVS Pharma Q4 FY2023 consolidated PAT drops at Rs. 3.34 Cr
The company has reported total income of Rs. 187.75 crores during the period ended March 31, 2023
The company has reported total income of Rs. 187.75 crores during the period ended March 31, 2023
The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023
The company has reported total income of Rs. 4467.35 crores during the quarter ended March 31, 2023
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023
The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
Subscribe To Our Newsletter & Stay Updated
